|
136
|
550
|
5tepA |
Crystal structure of hiv-1 reverse transcriptase in complex with 7-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)ethoxy)phenoxy)-2-naphthonitrile (jlj649), a non-nucleoside inhibitor |
|
102
|
424
|
5tepB |
Crystal structure of hiv-1 reverse transcriptase in complex with 7-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)ethoxy)phenoxy)-2-naphthonitrile (jlj649), a non-nucleoside inhibitor |
|
18
|
90
|
5t82A |
Hiv-1 reverse transcriptase thumb subdomain |
|
0
|
10
|
5t6zC |
Kir3dl1 in complex with hla-b*57:01-tw10 |
|
73
|
216
|
5t3aA |
Maedi-visna virus (mvv) integrase ccd-ctd (residues 60-275) |
|
103
|
428
|
5ovnB |
Crystal strucure of fiv reverse transcriptase |
|
113
|
532
|
5ovnA |
Crystal strucure of fiv reverse transcriptase |
|
43
|
152
|
5oi8A |
Dissociation of biochemical and antiretroviral activities of integrase-ledgf allosteric inhibitors revealed by resistance of a125 polymorphic hiv-1 |
|
40
|
152
|
5oi2A |
Dissociation of biochemical and antiretroviral activities of integrase-ledgf allosteric inhibitors revealed by resistance of a125 polymorphic hiv-1 |
|
44
|
152
|
5oi5A |
Dissociation of biochemical and antiretroviral activities of integrase-ledgf allosteric inhibitors revealed by resistance of a125 polymorphic hiv-1 |
|
41
|
152
|
5oi3A |
Dissociation of biochemical and antiretroviral activities of integrase-ledgf allosteric inhibitors revealed by resistance of a125 polymorphic hiv-1 |
|
43
|
152
|
5oiaA |
Dissociation of biochemical and antiretroviral activities of integrase-ledgf allosteric inhibitors revealed by resistance of a125 polymorphic hiv-1 |
|
151
|
537
|
5c24A |
Crystal structure of hiv-1 reverse transcriptase in complex with 7-((4-((4-cyanophenyl)amino)-1,3,5-triazin-2-yl)amino)-6,8-dimethylindolizine-2-carbonitrile (jlj605), a non-nucleoside inhibitor |
|
36
|
102
|
5kz9A |
Crystal structure of the rous sarcoma virus matrix protein. |
|
111
|
424
|
5k14B |
Hiv-1 reverse transcriptase in complex with a 2,6-difluorophenyl dapy analog |
|
18
|
99
|
5kaoA |
Crystal structure of wild type hiv-1 protease in complex with grl-10413 |
|
19
|
99
|
5jg1A |
Hiv-1 wild type protease with grl-031-14a (a adamantane p1-ligand with tetrahydropyrano-tetrahydrofuran in p2 and isobutylamine in p1') |
|
156
|
543
|
5k14A |
Hiv-1 reverse transcriptase in complex with a 2,6-difluorophenyl dapy analog |
|
52
|
154
|
5hrrA |
Hiv integrase catalytic domain containing f185k + a124n + t125s mutations complexed with gsk0002 |
|
161
|
554
|
5hbmA |
Crystal structure of a dihydroxycoumarin rnase h active-site inhibitor in complex with hiv-1 reverse transcriptase |
|
106
|
422
|
5fdlB |
Crystal structure of k103n/y181c mutant hiv-1 reverse transcriptase (rt) in complex with idx899 |
|
144
|
554
|
5fdlA |
Crystal structure of k103n/y181c mutant hiv-1 reverse transcriptase (rt) in complex with idx899 |
|
27
|
112
|
5fivA |
Structural studies of hiv and fiv proteases complexed with an efficient inhibitor of fiv pr |
|
48
|
153
|
5eu7A |
Crystal structure of hiv-1 integrase catalytic core in complex with fab |
|
18
|
99
|
5e5kA |
Joint x-ray/neutron structure of hiv-1 protease triple mutant (v32i,i47v,v82i) with darunavir at ph 4.3 |
|
131
|
640
|
5dmqA |
Crystal structure of mouse erf1 in complex with reverse transcriptase (rt) of moloney murine leukemia virus |
|
18
|
99
|
5dguA |
Crystal structure of hiv-1 protease inhibitors containing substituted fused-tetrahydropyranyl tetrahydrofuran as p2-ligand grl-004-11a |
|
37
|
160
|
5dmrA |
Crystal structure of c-terminal domain of mouse erf1 in complex with rnase h domain of rt of moloney murine leukemia virus |
|
8
|
53
|
5d7uA |
Crystal structure of the c-terminal domain of mmtv integrase |
|
18
|
99
|
5dgwA |
Crystal structure of hiv-1 protease inhibitor grl-105-11a containing substituted fused-tetrahydropyranyl tetrahydrofuran as p2-ligand |
|
111
|
424
|
5cymB |
Hiv-1 reverse transcriptase complexed with 4-iodopyrazole |
|
154
|
548
|
5cyqA |
Hiv-1 reverse transcriptase complexed with 4-bromopyrazole |
|
20
|
99
|
4yhqA |
Crystal structure of multidrug resistant clinical isolate pr20 with grl-5010a |
|
46
|
159
|
5cz2A |
Crystal structure of a two-domain fragment of mmtv integrase |
|
151
|
556
|
5cymA |
Hiv-1 reverse transcriptase complexed with 4-iodopyrazole |
|
117
|
424
|
5cyqB |
Hiv-1 reverse transcriptase complexed with 4-bromopyrazole |
|
52
|
162
|
5cz1A |
Crystal structure of the catalytic core domain of mmtv integrase |
|
16
|
99
|
5agzA |
Disubstituted bis-thf moieties as new p2 ligands in non-peptidal hiv- 1 protease inhibitors (ii) |
|
17
|
99
|
5ahaA |
Disubstituted bis-thf moieties as new p2 ligands in non-peptidal hiv- 1 protease inhibitors (ii) |
|
17
|
99
|
5ahbA |
Disubstituted bis-thf moieties as new p2 ligands in non-peptidal hiv- 1 protease inhibitors (ii) |
|
19
|
99
|
4ye3A |
Crystal structure of multidrug resistant hiv-1 protease clinical isolate pr20 with inhibitor grl-4410a |
|
16
|
99
|
5ahcA |
Disubstituted bis-thf moieties as new p2 ligands in non-peptidal hiv- 1 protease inhibitors (ii) |
|
16
|
99
|
5ah6A |
Disubstituted bis-thf moieties as new p2 ligands in non-peptidal hiv- 1 protease inhibitors (ii) |
|
18
|
99
|
5ah9A |
Disubstituted bis-thf moieties as new p2 ligands in non-peptidal hiv- 1 protease inhibitors (ii) |
|
16
|
99
|
5ah8A |
Disubstituted bis-thf moieties as new p2 ligands in non-peptidal hiv- 1 protease inhibitors (ii) |
|
16
|
99
|
5ah7A |
Disubstituted bis-thf moieties as new p2 ligands in non-peptidal hiv- 1 protease inhibitors (ii) |
|
21
|
116
|
4ydgA |
Crystal structure of compound 10 in complex with htlv-1 protease |
|
140
|
547
|
4we1A |
Crystal structure of hiv-1 reverse transcriptase in complex with 5-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)ethoxy)phenoxy)-2-naphthonitrile (jlj600) |
|
106
|
425
|
4we1B |
Crystal structure of hiv-1 reverse transcriptase in complex with 5-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)ethoxy)phenoxy)-2-naphthonitrile (jlj600) |
|
17
|
99
|
4upjA |
Human immunodeficiency virus type 2 protease mutant with lys 57 replaced by leu (k57l) complex with u097410 [4-hydroxy-3-[1-[3-[[[[(tert-butyloxycarbonyl) aminomethyl]carbonyl]amino]phenyl]propyl]coumarin |
